Erratum: How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial (Rheumatology (2004) vol. 43 (619-625))

E. L. Matteson, C. M. Weyand, J. W. Fulbright, T. J.H. Christianson, R. L. McClelland, J. J. Goronzy

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)1065
Number of pages1
Issue number8
StatePublished - Aug 2004

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Cite this